UPB
Upstream Bio, Inc.
-0.01 (-0.19%)5.32USD124K成交股數291M市值–本益比(近四季)92.3股價營收比-17.5%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 773K-18% | 1.0M+83% | 668K+10% | 683K+34% | 937K+46% | 566K | 607K-2% | 510K | 640K | – | 621K | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 36.1M | 36.6M | 40.2M | 33.0M | 37.9M | 25.8M | 15.4M | 14.1M | 11.7M | – | 7.8M | – |
| 銷售管理費用 | 7.1M | 8.1M | 6.7M | 5.5M | 7.4M | 6.8M | 4.1M | 4.0M | 4.0M | – | 2.2M | – |
| 營業利益 | −42.4M-4% | −43.6M+36% | −46.2M+144% | −37.8M+116% | −44.3M+195% | −32.0M | −18.9M+101% | −17.5M | −15.0M | – | −9.4M | – |
| 營業利益率 | -5,481.0% | -4,218.1% | -6,911.2% | -5,539.4% | -4,732.9% | -5,656.0% | -3,112.5% | -3,439.2% | -2,345.8% | – | -1,511.4% | – |
| 稅後淨利 | −39.7M-1% | −40.6M+49% | −42.5M+166% | −33.7M+130% | −40.0M+267% | −27.3M+130% | −16.0M+416% | −14.7M+478% | −10.9M | −11.8M | −3.1M | −2.5M |
| 淨利率 | -5,136.1% | -3,925.6% | -6,356.1% | -4,941.1% | -4,265.3% | -4,818.0% | -2,634.6% | -2,878.0% | -1,702.2% | – | -499.5% | – |
| 稀釋 EPS | -0.73-1% | -0.75+47% | -0.78-89% | -0.63-90% | -0.74-84% | -0.51 | -6.96+230% | -6.50 | -4.68 | – | -2.11 | – |
| 稀釋股數 | 54.6M | 54.3M | 53.9M | 53.9M | 53.8M | 53.6M | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 79.4M | 96.7M | 102M | 72.2M | 45.5M | 71.3M | 32.9M | 47.3M | 31.5M | 25.8M | 47.3M | – |
| 應收帳款 | 772K | 1.0M | 668K | 683K | 937K | 566K | 607K | – | – | 98K | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 281M | 318M | 354M | 391M | 421M | 456M | 233M | – | – | 117M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 10.2M | 14.1M | 14.0M | 12.6M | 11.8M | 10.6M | 12.1M | – | – | 9.4M | – | – |
| 股東權益 | 271M | 304M | 340M | 379M | 409M | 446M | −160M | −147M | −133M | −123M | −112M | −110M |
| 負債比 | 3.6% | 4.4% | 4.0% | 3.2% | 2.8% | 2.3% | 5.2% | – | – | 8.0% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −47.9M+16% | – | – | – | −41.2M | – | – | −17.6M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 49K | – | – | – | 43K | – | – | 13K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.9M | +20.4% | −143M | -5,026.0% | -2.66 | −133M |
| FY2024 | 2.4M | -0.4% | −62.8M | -2,650.0% | -5.58 | −59.7M |
| FY2023 | 2.4M | – | −20.5M | -862.9% | -12.95 | −38.1M |